TPSF
CORT icon

Texas Permanent School Fund’s Corcept Therapeutics CORT Stock Holding History

Texas Permanent School Fund’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-79,390
Closed -$2M – 313
2024
Q1 		$2M Buy
79,390
+1,435
+2% +$33.9K 0.02% 1064
2023
Q4 		$2.53M Buy
77,955
+1,314
+2% +$36.1K 0.02% 921
2023
Q3 		$2.09M Sell
76,641
-2,959
-4% -$85.6K 0.02% 942
2023
Q2 		$1.77M Sell
79,600
-6,321
-7% -$145K 0.02% 1038
2023
Q1 		$1.86M Buy
85,921
+21,510
+33% +$472K 0.02% 1003
2022
Q4 		$1.31M Sell
64,411
-4,144
-6% -$104K 0.02% 986
2022
Q3 		$1.76M Sell
68,555
-561
-0.8% -$15K 0.03% 821
2022
Q2 		$1.64M Buy
69,116
+1,524
+2% +$33.2K 0.03% 887
2022
Q1 		$1.52M Sell
67,592
-803
-1% -$17.1K 0.02% 992
2021
Q4 		$1.35M Sell
68,395
-8,785
-11% -$178K 0.02% 1097
2021
Q3 		$1.52M Sell
77,180
-1,045
-1% -$21.9K 0.02% 1039
2021
Q2 		$1.72M Sell
78,225
-654
-0.8% -$14.6K 0.02% 1006
2021
Q1 		$1.88M Sell
78,879
-5,074
-6% -$135K 0.02% 943
2020
Q4 		$2.2M Sell
83,953
-13,208
-14% -$278K 0.03% 791
2020
Q3 		$1.69M Buy
97,161
+15,670
+19% +$250K 0.02% 868
2020
Q2 		$1.37M Sell
81,491
-6,114
-7% -$85.9K 0.02% 885
2020
Q1 		$1.04M Buy
87,605
+17,253
+25% +$214K 0.02% 942
2019
Q4 		$851K Buy
70,352
+709
+1% +$9.87K 0.01% 1166
2019
Q3 		$984K Sell
69,643
-1,293
-2% -$15.9K 0.02% 1071
2019
Q2 		$791K Buy
70,936
+51
+0.1% +$568 0.01% 1159
2019
Q1 		$832K Buy
70,885
+2,122
+3% +$26.4K 0.01% 1152
2018
Q4 		$919K Buy
68,763
+2,315
+3% +$30.6K 0.02% 1043
2018
Q3 		$932K Buy
66,448
+4,718
+8% +$65.9K 0.01% 1141
2018
Q2 		$970K Sell
61,730
-1,365
-2% -$23.7K 0.01% 1120
2018
Q1 		$1.04M Buy
63,095
+21,167
+50% +$392K 0.01% 1061
2017
Q4 		$757K Buy
+41,928
New +$759K 0.01% 1202

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Texas Permanent School Fund's CORT Position: Q2 2024 in Review

Texas Permanent School Fund sold out of Corcept Therapeutics (CORT) in Q2 2024, closing a stake of 79,390 shares — an estimated $2M sold.

Texas Permanent School Fund first reported a position in CORT in Q4 2017 and held it in 26 quarters. The position peaked at $2.53M in Q4 2023. 286 funds tracked by Wall St. Rank hold CORT as of Q2 2024.

  • Texas Permanent School Fund reported no remaining Corcept Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Texas Permanent School Fund sold 79,390 Corcept Therapeutics shares in Q2 2024, an estimated $2M.
  • Texas Permanent School Fund first reported a position in Corcept Therapeutics in Q4 2017 and held it in 26 quarters.
  • Texas Permanent School Fund's Corcept Therapeutics position peaked at $2.53M in Q4 2023.
  • 286 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2024.

Based on Texas Permanent School Fund's 13F filing for Q2 2024, filed 7 Aug 2024.